1,1-difluoro-6-azaspiro[2.6]nonane hydrochloride, 95.0%, 2.5g

[(1-isopropyl-1,2,3,4-tetrahydro-6-quinolinyl)methyl]methylamine oxalate, 95.0%, 1g

Volumetric flasks DURAN® Class B, 25 ml, 10/19, 2 Piece(s)

1-(2-Pyridyl)-2-thiourea, 98.0%, 1g

TERT-BUTYL 4-((5-(METHOXYCARBONYL)-1-METHYL-1H-PYRAZOL-3-YL)OXY)PIPERIDINE-1-CARBOXYLATE, 95.0%, 250mg

D-Tyrosine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-O-(phenylmethyl)-, 98%, 10g

Oxion Inverso OX.2453-PLF with LWD Plan fluarex 10x/20x/40x objectives, 4-position filter blocks and XY cross table

4-tert-butyl-N'-hydroxybenzene-1-carboximidamide, 100mg

5-(Pyridin-4-yl)isoxazole-3-carboxylic acid, 95.0%, 250mg

4,7,10,13,16,19,22,25,28-Nonaoxahentriacontanedioic acid, 1,31-bis(2,5-dioxo-1-pyrrolidinyl) ester, 97%, 25mg

GC capillary column ROTI®Cap-1, 15 m, 0.25 mm, 0.25 µm, 1 Piece(s)

4-(2-Chloro-6-fluoro-3-methylbenzyl)morpholine, 97%, 500mg

N-(4-Cyanophenyl)-2-chloropropanamide, 95%, 2g